Standout Papers

Cardiovascular disease in... 2022 2026 2023 2024 2022 50 100 150 200
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation benchmark for papers published in the same subfield and year, or reaches the top citation threshold in at least one of its specific research topics.

  1. Cardiovascular disease in type 2 diabetes mellitus: progress toward personalized management
    2022 222 citations Chengxu Ma, Xiaoni Ma et al. Cardiovascular Diabetology profile →

Immediate Impact

55 hit
Sub-graph 1 of 24

Citing Papers

Type 2 Diabetes Mellitus: A Comprehensive Review of Pathophysiology, Comorbidities, and Emerging Therapies
2025 Hit
Role of macrophage in intervertebral disc degeneration
2025 Hit
3 intermediate papers

Works of Songbo Fu being referenced

Role of Pyroptosis in Intervertebral Disc Degeneration and Its Therapeutic Implications
2022
Efficacy and safety of dapagliflozin as monotherapy in patients with type 2 diabetes mellitus
2019
and 1 more

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Songbo Fu 293 191 107 104 95 54 760
Colin Davenport 270 0.9× 157 0.8× 85 0.8× 94 0.9× 113 1.2× 49 830
Grażyna Adler 287 1.0× 109 0.6× 112 1.0× 85 0.8× 70 0.7× 86 869
Xin Su 226 0.8× 208 1.1× 83 0.8× 191 1.8× 164 1.7× 48 832
Xiaomu Kong 239 0.8× 170 0.9× 64 0.6× 92 0.9× 109 1.1× 42 709
Zhen Sun 308 1.1× 106 0.6× 79 0.7× 166 1.6× 115 1.2× 40 783
Jiaqi Chen 270 0.9× 119 0.6× 87 0.8× 123 1.2× 97 1.0× 53 669
Lihua Ni 381 1.3× 197 1.0× 148 1.4× 72 0.7× 39 0.4× 39 800
Jianying Niu 213 0.7× 93 0.5× 59 0.6× 80 0.8× 78 0.8× 54 899
Yi-Jen Hung 240 0.8× 129 0.7× 49 0.5× 98 0.9× 98 1.0× 30 700
Randa H. Mohamed 214 0.7× 93 0.5× 106 1.0× 56 0.5× 74 0.8× 42 726

All Works

Loading papers...

Rankless by CCL
2026